Allergy: European Journal of Allergy and Clinical Immunology: Introduction

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 57, Issue 75, 2002, Pages 5-7

  Canonica, G Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; DESLORATADINE; GLUCOCORTICOID; IMMUNOGLOBULIN E;

AIR POLLUTION; ALLERGIC RHINITIS; ALLERGY; COMORBIDITY; CORTICOSTEROID THERAPY; EDITORIAL; HEALTH CARE COST; HEALTH SURVEY; HUMAN; MEDICAL SOCIETY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIETY; ARTICLE; ASTHMA; EUROPE; PERENNIAL RHINITIS;

ASTHMA; EUROPE; HUMANS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0036966678     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. EUROPEAN FEDERATION OF ALLERGY AND AIRWAY DISEASES PATIENTS' ASSOCIATIONS. Respiratory allergies. http://www.efanet.org/imgs/pdf/respiratory_allergies.pdf. Accessed 18 November 2002.
2. JANSON C, ANTO J, BURNEY P et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001;18:598-611.
3. STRACHAN D, SIBBALD B, WEILAND S et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8:161-176.
4. FREYE HB, KING J, LITWIN CM. Variations of pollen and mold concentrations in 1998 during the strong El Nino event of 1997-1998 and their impact on clinical exacerbations of allergic rhinitis, asthma, and sinusitis. Allergy Asthma Proc 2001;22:239-247.
5. HAJAT S, HAINES A, ATKINSON RW, BREMNER SA, ANDERSON HR, EMBERLIN J. Association between air pollution and daily consultations with general practitioners for allergic rhinitis in London, United Kingdom. Am J Epidemiol 2001;153:704-714.
6. HEINRICH J, HOLSCHER B, BOLTE G, WINKLER G. Allergic sensitization and diet: ecological analysis in selected European cities. Eur Respir J 2001;17:395-402.
7. KAY AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001;344:30-37.
8. KRAMER U, KOCH T, RANFT U, RING J, BEHRENDT H. Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology 2000;11:64-70.
9. LEYNAERT B, NEUKIRCH C, JARVIS D, CHINN S, BURNEY P, NEUKIRCH F. Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med 2001;164:1829-1834.
10. MCKEEVER TM, LEWIS SA, SMITH C et al. Siblings, multiple births, and the incidence of allergic disease: a birth cohort study using the West Midlands general practice research database. Thorax 2001;56:758-762.
11. EUROSTAT (STATISTICAL OFFICE OF THE EUROPEAN COMMISSION). Gaining better knowledge of the pressures on our environment. News release issued 7 June 2001. http://www.europa.eu.int/comm/eurostat/Public/datashop/print-product/ EN?catalogue=Eurostat&product=8-07062001-EN-AP-EN&mode=download. Accessed 18 November 2002.
12. MELTZER EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(Suppl. 1):S45-S53.
13. VAN CAUWENBERGE P, BACHERT C, PASSALACQUA G et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-134.
14. O'DONNELL BF, LAWLOR F, SIMPSON J, MORGAN M, GREAVES MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136:197-201.
15. CRYSTAL-PETERS J, CROWN WH, GOETZEL RZ, SCHUTT DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000;6:373-378.
16. QIDWAI JC, WATSON GS, WEILER JM. Sedation, cognition and antihistamines. Curr Allergy Asthma Rep 2002;2:216-222.
17. DESSI P, ALLAERT FA, URBINELLI R, VERRIERE JL. Medico-economic aspects of the management of perennial allergic rhinitis in general medicine. Allerg Immunol (Paris) 1998;30:277-283.
18. SZUCS TD, ANDERHUB H, RUTISHAUSER M. The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J 1999;13:281-286.
19. WEISSFLOG D, MATTHYS H, VIRCHOW JC Jr. Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany. Dtsch Med Wochenschr 2001;126:803-808.
20. VAN CAUWENBERGE P. Advances in allergy management. Allergy 2002;57(Suppl. 75):29-36.
21. VERMEIRE PA, RABE KF, SORIANO JB, MAIER WC. Asthma control and differences in management practices across seven European countries. Respir Med 2002;96:142-149.
22. VALOVIRTA E. Paediatric asthma pan European survey. http://www.efanet.org/imgs/pdf/paediatric_asthma.pdf. Accessed 18 November 2002.
23. CUFFEL B, WAMBOLDT M, BORISH L, KENNEDY S, CRYSTAL-PETERS J. Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics 1999;40:491-496.
24. BOUSQUET J, VAN CAUWENBERGE P, KHALTAEV N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108 (Suppl. 5):S147-S334.
25. FOKKENS WJ, GODTHELP T, HOLM AF, KLEIN-JAN A. Local corticosteroid treatment: the effect on cells and cytokines in nasal allergic inflammation. Am J Rhinol 1998;12:21-26.